# Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa

> **NCT02793960** · PHASE1 · COMPLETED · sponsor: **Shasa Hu** · enrollment: 11 (actual)

## Conditions studied

- Epidermolysis Bullosa

## Interventions

- **DRUG:** topical BPM31510 3.0% Cream

## Key facts

- **NCT ID:** NCT02793960
- **Lead sponsor:** Shasa Hu
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-10
- **Primary completion:** 2019-08-26
- **Final completion:** 2019-08-26
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-06-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02793960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02793960, "Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02793960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*